Tag Archives: INSY

Insys Therapeutics

Insys Therapeutics Reports Second Quarter 2016 Results

Insys Therapeutics Reports Second Quarter 2016 Results

PHOENIX, Aug. 3, 2016 /Weed Wire/ — Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced financial results for the three-month period ended June 30, 2016.

Insys Therapeutics

Insys Therapeutics Successfully Completes Safety and Pharmacokinetic (PK) Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients

PHOENIX, May 24, 2016 /Weed Wire/ — Insys Therapeutics, Inc. (NASDAQ: INSY) (“Insys” or “the Company”) today announced that it has successfully completed its Phase 1/Phase 2 safety and pharmacokinetic (PK) study in pediatric subjects with treatment-resistant epilepsy.

Don't Fight the Tape

Don’t Fight the Tape: Cannabis Stocks Subject to Broad Market Swings

Investors may be lulled into thinking that stocks they own or study in the cannabis space are insulated from what’s happening in the broader market. But that’s simply not true, and violates one of the oldest maxims in investing: Don’t fight the tape.


Are Cannabis Stocks Riding a Market Wave?

In the past few weeks we have seen some massive volatility in the most active cannabis stocks. At the same time we have seen broad market indexes like the NASDAQ and the S&P 500 hit new record highs, begging the question of whether the cannabis stocks are just following general momentum.

stock forecast

What the 5 Largest Cannabis Stocks Can Tell Us

The early leaders in market cap (the total value of publicly-traded equity) in a expanding industry like cannabis can tell us a lot. These companies have a lot of advantages by being on this perch, but also some responsibilities.

Online Medical Marijuana & CBD Dispensary Directory Provides Patients with User-Friendly Cannabis App to Identify Products, Various Strains & Dispensary Locations

CORAL SPRINGS, Florida, October 7, 2014 /PRNewswire/ -Biotech and Pharmaceutical companies focus on the development and commercialization of therapeutics for patients with infectious diseases as well as forecasts project legal medical marijuana.